Beam Therapeutics Statistics
Total Valuation
BEAM has a market cap or net worth of $2.72 billion. The enterprise value is $1.81 billion.
| Market Cap | 2.72B |
| Enterprise Value | 1.81B |
Important Dates
The last earnings date was Tuesday, August 4, 2026, before market open.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BEAM has 99.93 million shares outstanding. The number of shares has increased by 16.32% in one year.
| Current Share Class | 99.54M |
| Shares Outstanding | 99.93M |
| Shares Change (YoY) | +16.32% |
| Shares Change (QoQ) | +1.03% |
| Owned by Insiders (%) | 1.45% |
| Owned by Institutions (%) | 95.68% |
| Float | 87.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 17.78 |
| Forward PS | 36.27 |
| PB Ratio | 2.42 |
| P/TBV Ratio | 2.38 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 11.63 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.22 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -18.06% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 15.04% |
| Revenue Per Employee | $298,918 |
| Profits Per Employee | -$165,747 |
| Employee Count | 522 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +41.00% in the last 52 weeks. The beta is 2.21, so BEAM's price volatility has been higher than the market average.
| Beta (5Y) | 2.21 |
| 52-Week Price Change | +41.00% |
| 50-Day Moving Average | 30.69 |
| 200-Day Moving Average | 28.12 |
| Relative Strength Index (RSI) | 43.96 |
| Average Volume (20 Days) | 2,036,542 |
Short Selling Information
The latest short interest is 23.22 million, so 23.23% of the outstanding shares have been sold short.
| Short Interest | 23.22M |
| Short Previous Month | 22.88M |
| Short % of Shares Out | 23.23% |
| Short % of Float | 26.39% |
| Short Ratio (days to cover) | 8.56 |
Income Statement
In the last 12 months, BEAM had revenue of $156.04 million and -$86.52 million in losses. Loss per share was -$0.84.
| Revenue | 156.04M |
| Gross Profit | -252.63M |
| Operating Income | -378.02M |
| Pretax Income | -86.52M |
| Net Income | -86.52M |
| EBITDA | -355.78M |
| EBIT | -378.02M |
| Loss Per Share | -$0.84 |
Balance Sheet
The company has $1.21 billion in cash and $250.82 million in debt, with a net cash position of $960.83 million or $9.62 per share.
| Cash & Cash Equivalents | 1.21B |
| Total Debt | 250.82M |
| Net Cash | 960.83M |
| Net Cash Per Share | $9.62 |
| Equity (Book Value) | 1.16B |
| Book Value Per Share | 11.71 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was -$369.73 million and capital expenditures -$14.11 million, giving a free cash flow of -$383.84 million.
| Operating Cash Flow | -369.73M |
| Capital Expenditures | -14.11M |
| Depreciation & Amortization | 22.44M |
| Net Borrowing | 93.89M |
| Free Cash Flow | -383.84M |
| FCF Per Share | -$3.84 |
Margins
Gross margin is -161.91%, with operating and profit margins of -242.27% and -55.45%.
| Gross Margin | -161.91% |
| Operating Margin | -242.27% |
| Pretax Margin | -55.45% |
| Profit Margin | -55.45% |
| EBITDA Margin | -228.01% |
| EBIT Margin | -242.27% |
| FCF Margin | n/a |
Dividends & Yields
BEAM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.32% |
| Shareholder Yield | -16.32% |
| Earnings Yield | -3.12% |
| FCF Yield | -13.83% |
Analyst Forecast
The average price target for BEAM is $52.23, which is 91.53% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $52.23 |
| Price Target Difference | 91.53% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (3Y) | 5.02% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |